IceCure Medical Ltd (ICCM)
NASDAQ: ICCM
· Real-Time Price · USD
0.90
0.06 (6.94%)
At close: Aug 15, 2025, 12:45 PM
Company Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body.
It offers ProSense system, a cryoablation solution for the treatment of breast tumors.
The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd
| Country | IL |
| IPO Date | Aug 26, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 64 |
| CEO | Eyal Shamir |
Contact Details
Address: 7 Ha’Eshel Street Caesarea, IL | |
| Website | https://www.icecure-medical.com |
Stock Details
| Ticker Symbol | ICCM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001584371 |
| CUSIP Number | M53071136 |
| ISIN Number | IL0011224156 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eyal Shamir | Chief Executive Officer & Director |
| Ronen Tsimerman CPA | Chief Financial Officer & Chief Operating Officer |
| Galit Malik | Vice President of Operations & Service |
| Merav Nir Dotan | Vice President of Human Resources |
| Shad Good | Vice President of Sales for North America |
| Tlalit Bussi Tel-Tzure | Vice President of Business Development & Global Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2025 | 6-K | Filing |
| Aug 01, 2025 | 6-K/A | [Amend] Filing |
| Aug 01, 2025 | POS AM | Filing |
| Aug 01, 2025 | 6-K | Filing |
| Jul 28, 2025 | 424B3 | Filing |
| Jul 28, 2025 | 6-K | Filing |
| Jul 25, 2025 | 6-K | Filing |
| Jul 16, 2025 | 424B3 | Filing |
| Jul 16, 2025 | 6-K | Filing |
| Jul 10, 2025 | 6-K | Filing |